TrialDiabetes, obesity & metabolism2019

Improved treatment satisfaction in patients with type 2 diabetes treated with once-weekly semaglutide in the SUSTAIN trials.

Johan Jendle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.